Suchergebnisse - "Lederer, David J."

PubPharm (310)

1

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

enthalten in: bioRxiv.org | 2024

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

2

Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma : VOYAGE Study

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Bacharier, L. | Guilbert, T. | Katelaris, C. | +13

3

Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma

enthalten in: Respiratory medicine | 2024

von Papi, A. | Castro, M. | Corren, J. | +13

4

Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma

enthalten in: The Journal of allergy and clinical immunology | 2024

von Bacharier, L. | Pavord, I. | Maspero, J. | +12

5

Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION) : an open-label extension study

enthalten in: The Lancet. Respiratory medicine | 2024

von Bacharier, L. | Maspero, J. | Katelaris, C. | +38

6

Dupilumab leads to better-controlled asthma and quality of life in children : the VOYAGE study

enthalten in: The European respiratory journal | 2023

von Fiocchi, A. | Phipatanakul, W. | Zeiger, R. | +11

7

Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose

enthalten in: Allergy | 2023

von Pavord, I. | Bourdin, A. | Papi, A. | +11

8

Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Corren, J. | Hanania, N. | Busse, W. | +10

9

Accuracy and Reproducibility of Automated Measurement of Body Composition : A Lung Transplant Body Composition Cohort Study

enthalten in: Annals of the American Thoracic Society | 2023

von Anderson, M. | Diamond, J. | Shashaty, M. | +8

10

Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma

enthalten in: Allergy | 2023

von Papadopoulos, N. | Szefler, S. | Bacharier, L. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]